GREG ZANTE Insider Trading
Get free email notifications about insider trading for GREG ZANTE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREG ZANTE. GREG ZANTE is a Sr Dir., Finance and Admin in SANGAMO BIOSCIENCES INC ($SGMO) and a Chief Financial Officer in Viking Therapeutics, Inc. ($VKTX).
Address: C/O SANGAMO BIOSCIENCES, INC STE-A-100 POINT RICHMOND TECH, 501 CANAL BLVD, RICHMOND 94804 CA
Companies in which GREG ZANTE is an Insider
SANGAMO THERAPEUTICS, INC
Trading Symbol: SGMOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GREG ZANTE: Sr Dir., Finance and Admin
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 23 2004
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viking Therapeutics, Inc.
Trading Symbol: VKTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREG ZANTE: Chief Financial Officer
Holdings: 89,751 shares
Current Value: $130,139
Latest Transaction: Jan 19 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GREG ZANTE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 19 2021 | VKTX | Viking Therapeutic ... | ZANTE GREG | Chief Financial Off ... | Payment of Exercise | F | 6.68 | 808 | 5,397 | 89,751 | 90.6 K to 89.8 K (-0.89 %) |
Jan 06 2021 | VKTX | Viking Therapeutic ... | ZANTE GREG | Chief Financial Off ... | Option Exercise | A | 5.80 | 78,000 | 452,400 | 78,000 | |
Jan 06 2021 | VKTX | Viking Therapeutic ... | ZANTE GREG | Chief Financial Off ... | Payment of Exercise | F | 5.80 | 2,787 | 16,165 | 90,559 | 93.3 K to 90.6 K (-2.99 %) |
Jan 06 2021 | VKTX | Viking Therapeutic ... | ZANTE GREG | Chief Financial Off ... | Grant | A | 0.00 | 6,783 | 0 | 93,346 | 86.6 K to 93.3 K (+7.84 %) |
Jan 06 2021 | VKTX | Viking Therapeutic ... | ZANTE GREG | Chief Financial Off ... | Grant | A | 0.00 | 64,667 | 0 | 86,563 | 21.9 K to 86.6 K (+295.34 %) |
Apr 23 2004 | SGMO | SANGAMO BIOSCIENCE ... | ZANTE GREG | Sr Dir., Finance an ... | Option Exercise | A | 4.92 | 20,000 | 98,400 | 20,000 |